These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11397626)

  • 21. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Caron F; Etienne M
    Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?].
    Viñuela L; de Frutos-Serna M; Asensio ML; Muñoz-Bellido JL; García-Sánchez JE
    Rev Esp Quimioter; 2013 Jun; 26(2):159-61. PubMed ID: 23817654
    [No Abstract]   [Full Text] [Related]  

  • 24. The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
    Anderson K
    Med J Aust; 1970 Aug; 2(9):409-11. PubMed ID: 4924022
    [No Abstract]   [Full Text] [Related]  

  • 25. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transferable antibiotic resistance in Escherichia coli isolated from urinary-tract infections: hospital v. community patients.
    Rotimi VO; Emina PA; Eke PI
    Afr J Med Med Sci; 1984; 13(1-2):47-53. PubMed ID: 6087639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of increase in resistance to quinolones in general practice isolates of Escherichia coli.
    Weber P; Plaisance JJ; Mancy C
    J Antimicrob Chemother; 1994 Jul; 34(1):187-8. PubMed ID: 7961211
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children.
    Allen UD; MacDonald N; Fuite L; Chan F; Stephens D
    CMAJ; 1999 May; 160(10):1436-40. PubMed ID: 10352632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The sensitivity of the uropathogenic Escherichia coli strains to antibiotics, bacteriophages and bactericidal serum activity].
    Drulis-Kawa Z; Weber-Dabrowska B; Lewczyk E; Jankowski S; Doroszkiewicz W
    Pol Merkur Lekarski; 2002 Dec; 13(78):470-2. PubMed ID: 12666443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of urinary tract infections in children with trimethoprim-sulfamethoxypyridazine].
    Rodríguez W; Delucchi C; Bidegain MA; Rodríguez MS; Gleisner A; Figueroa S
    Rev Chil Pediatr; 1983; 54(6):402-6. PubMed ID: 6379766
    [No Abstract]   [Full Text] [Related]  

  • 31. [Activity of nalidixic acid and fluoroquinolones on Escherichia coli strains isolated from non-complicated urinary infections (reseau TSN - France, 1999 - 2001)].
    Lecaillon E; Blosser-Middleton R; Sahm D; Jones M
    Med Mal Infect; 2004 Oct; 34(10):450-4. PubMed ID: 15747469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M; Yuce A; Yulug N
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary tract infections caused by beta-lactam-sensitive Corynebacterium urealyticum strains.
    Zapardiel J; Nieto E; Soriano F
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):174-6. PubMed ID: 9105850
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrofloxacin resistance in Escherichia coli isolated from dogs with urinary tract infections.
    Cooke CL; Singer RS; Jang SS; Hirsh DC
    J Am Vet Med Assoc; 2002 Jan; 220(2):190-2. PubMed ID: 12126128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing incidence of quinolone-resistant E. coli from urinary cultures in Ankara-Pursaklar region.
    Tekin O; Catal F; Ibýk B; Açýkgöz ZC
    Int J Antimicrob Agents; 2004 Apr; 23(4):416-7. PubMed ID: 15081097
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fluoroquinolone resistance of human pathogenic bacteria. Resistant E coli now appearing in Sweden].
    Osterlund A; Olsson-Liljequist B
    Lakartidningen; 1999 Apr; 96(16):1965-6. PubMed ID: 10330864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
    Jones RN; Beach ML; Pfaller MA
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):161-3. PubMed ID: 11750171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.